AAV Gene Therapy in a Canine Model of MPS1 Prevents and Reverses Corneal Blindness

被引:0
|
作者
Hirsch, Matthew [1 ,2 ]
Gilger, Brian C. [3 ]
Llanga, Telmo [1 ]
Davis, Richard [1 ]
Kurtzberg, Joanne [4 ]
Samulski, Richard J. [2 ]
Miyadera, Keiko [5 ]
机构
[1] Univ N Carolina, Ophthalmol, Chapel Hill, NC USA
[2] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
[3] North Carolina State Univ, Raleigh, NC USA
[4] Duke Univ, Durham, NC USA
[5] Univ Penn, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
4480
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness
    Miyadera, Keiko
    Santana, Evelyn
    Roszak, Karolina
    Iffrig, Sommer
    Visel, Meike
    Iwabe, Simone
    Boyd, Ryan F.
    Bartoe, Joshua T.
    Sato, Yu
    Gray, Alexa
    Ripolles-Garcia, Ana
    Dufour, Valerie L.
    Byrne, Leah C.
    Flannery, John G.
    Beltran, William A.
    Aguirre, Gustavo D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (13)
  • [22] AAV Mediated Gene Therapy Prevents Emphysema in a Novel Mouse Model of Alpha-1 Antitrypsin Deficiency
    Zieger, Marina
    Borel, Florie
    Greer, Cynthia
    Mueller, Christian
    MOLECULAR THERAPY, 2018, 26 (05) : 353 - 354
  • [23] Germ cell aneuploidy in zebrafish with mutations in the mitotic checkpoint gene mps1
    Poss, KD
    Nechiporuk, A
    Stringer, KF
    Lee, C
    Keating, MT
    GENES & DEVELOPMENT, 2004, 18 (13) : 1527 - 1532
  • [24] Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model
    Hinderer, Christian
    Bell, Peter
    Louboutin, Jean-Pierre
    Katz, Nathan
    Zhu, Yanqing
    Lin, Gloria
    Choa, Ruth
    Bagel, Jessica
    O'Donnell, Patricia
    Fitzgerald, Caitlin A.
    Langan, Therese
    Wang, Ping
    Casal, Margret L.
    Haskins, Mark E.
    Wilson, James M.
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (1-2) : 124 - 130
  • [25] AAV8 mediated gene therapy for corneal cystinosis
    Duy Nguyen
    Du, Hongjun
    Bedell, Matthew
    Grob, Seanna
    Luo, Jing
    Quach, John
    Shaw, Peter
    Cherqui, Stephanie
    Zhang, Kang
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [26] Long-term functional rescue following a AAV-based gene therapy in canine model of LRIT3-congenital stationary night blindness
    Takahashi, Kei
    Kwok, Jennifer C.
    Sato, Yu
    Aguirre, Gustavo D.
    Miyadera, Keiko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [27] Humoral immune response limits gene therapy in canine MPS I
    Shull, R
    Lu, XC
    Dube, I
    Lutzko, C
    Kruth, S
    AbramsOgg, A
    Kiem, HP
    Goehle, S
    Schuening, F
    Millan, C
    Carter, R
    BLOOD, 1996, 88 (01) : 377 - 379
  • [28] AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
    Bennett, Jean
    Ashtari, Manzar
    Wellman, Jennifer
    Marshall, Kathleen A.
    Cyckowski, Laura L.
    Chung, Daniel C.
    McCague, Sarah
    Pierce, Eric A.
    Chen, Yifeng
    Bennicelli, Jeannette L.
    Zhu, Xiaosong
    Ying, Gui-shuang
    Sun, Junwei
    Wright, J. Fraser
    Auricchio, Alberto
    Simonelli, Francesca
    Shindler, Kenneth S.
    Mingozzi, Federico
    High, Katherine A.
    Maguire, Albert M.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (120)
  • [29] AAV1.NT-3 gene therapy prevents age-related sarcopenia
    Ozes, Burcak
    Tong, Lingying
    Myers, Morgan
    Moss, Kyle
    Ridgley, Alicia
    Sahenk, Zarife
    AGING-US, 2023, 15 (05): : 1306 - 1329
  • [30] AAV9-cBIN1 gene therapy rescues chronic heart failure due to ischemic cardiomyopathy in a canine model
    Khan, Muhammad S.
    Smego, Douglas
    Li, Jing
    Ishidoya, Yuki
    Offei, Emmanuel
    Ruiz Castillo, Martha Sofia
    Hirahara, Annie M.
    Balmaceda, Pia
    Hunter, Jennifer
    Athavale, Anand
    Revelo, Monica P.
    Palatinus, Joseph A.
    Selzman, Craig H.
    Ranjan, Ravi
    Hong, Tingting
    Dosdall, Derek J.
    Shaw, Robin M.
    COMMUNICATIONS MEDICINE, 2025, 5 (01):